Drug Profile
DTP hepatitis B vaccine - Sanofi
Alternative Names: ShantetraLatest Information Update: 31 Mar 2022
Price :
$50
*
At a glance
- Originator Shantha Biotechnics
- Class Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Diphtheria; Hepatitis B; Pertussis; Tetanus
Most Recent Events
- 12 Sep 2005 Launched for Diphtheria in India (IM)
- 12 Sep 2005 Launched for Hepatitis B prevention in India (IM)
- 12 Sep 2005 Launched for Pertussis in India (IM)